NCT03144830

Brief Summary

This study will examine the safety and feasibility of using an exoskeleton in subjects who are less than 6 months post spinal cord injury (SCI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2016

Completed
11 months until next milestone

First Posted

Study publicly available on registry

May 9, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

May 16, 2019

Status Verified

May 1, 2019

Enrollment Period

1.7 years

First QC Date

April 20, 2016

Last Update Submit

May 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline cardiorespiratory status throughout each of the 25 sessions

    Blood pressure, heart rate and peripheral oxygen saturation and will be used to identify any cardiovascular issues of orthostatic hypotension or autonomic dysreflexia.

    Every 15 minutes during each training session including: pre and post initial stand, at 15 minute intervals during training and at the end of each of the 25 total sessions, on average of 2 months

Secondary Outcomes (6)

  • Skin integrity

    At the beginning and end of each training session for 25 sessions, on average of 2 months

  • Falls

    From onset to cessation of each training session for 25 sessions, on average of 2 months

  • Pain visual analogue scale

    At the beginning and end of each training session for 25 sessions, on average of 2 months

  • Borg scale of perceived exertion

    At the beginning, mid point (30 min) and end (60 min) of each training session for 25 sessions, on average of 2 months

  • 10 meter walk test

    Training sessions 1, 13 and 25 out of the 25 total sessions, on average of 2 months

  • +1 more secondary outcomes

Study Arms (1)

Overground walking program

EXPERIMENTAL

Study participant will be involved in an indoor, overground walking program using an exoskeleton wearable walking device under the supervision of a physiotherapist.

Device: Exoskeleton

Interventions

This is an open study and so all participants involved with be using the exoskeleton to determine the safety and feasibility of its use during the acute rehabilitation phase.

Also known as: Ekso GT
Overground walking program

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged 15 and older with acute SCI (\<6 months post) Etiology of SCI can be traumatic or non traumatic Includes motor complete (AIS A,B) and motor incomplete (AIS C,D) at C7 or below.
  • Participants must be able to follow 2 step commands Participants must be deemed medically stable by responsible physician or physiatrist
  • Spine considered stable by surgeon
  • Surgical wound is approximated and surrounding tissue appears healthy
  • Participant does not require supplemental Oxygen
  • Participant is able to have any IV or other lines disconnected.
  • Must meet manufacturer's requirements for use of Ekso GT:

You may not qualify if:

  • Range of motion (ROM) restrictions that would prevent a patient from achieving a normal, reciprocal gait pattern, or would restrict a patient from completing normal sit-to-stand or stand-to-sit transitions Spinal instability Untreated deep vein thrombosis (DVT) Decreased standing tolerance due to orthostatic hypotension Significant osteoporosis that prevents safe standing or may increase the risk of fracture caused by standing or walking Uncontrolled spasticity - score of 3 or higher on modified Ashworth Scale Uncontrolled Autonomic Dysreflexia (AD) Skin integrity issues on contact surfaces of the device or on surfaces that would prohibit sitting (sacrum, greater trochanter, proximal tibia)
  • Upper leg length discrepancy greater than half an inch (\> .5") or lower leg discrepancy greater than three-quarters of an inch (\>.75") Cognitive impairments resulting in motor planning or impulsivity concerns Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foothills Medical Centre

Calgary, Alberta, T2N2T9, Canada

Location

MeSH Terms

Conditions

Spinal Cord Injuries

Interventions

Exoskeleton Device

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Officials

  • Chester Ho, MD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 20, 2016

First Posted

May 9, 2017

Study Start

June 1, 2016

Primary Completion

February 1, 2018

Study Completion

February 1, 2018

Last Updated

May 16, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations